LIFECORE BIOMEDICAL, INC. current report, Q3 FY2017

Business Context and Reporting Period

This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc.) on July 25, 2017. The report announces the consolidated financial results for the fourth quarter and the full fiscal year ended May 28, 2017.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.

Material Changes

The filing text does not provide data to compare current results against prior periods. Specific material changes are detailed in the referenced Exhibit 99.1.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. The report explicitly states that the information is furnished and not "filed" for purposes of Section 18 of the Exchange Act.

Investor Verification Checklist

  • Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
  • Review Exhibit 99.1 (Press Release dated July 25, 2017) for actual financial figures.
  • Confirm the fiscal year end date of May 28, 2017, for accurate period comparison.
  • Note that the financial data in this 8-K is furnished, not filed, limiting its legal incorporation into other filings.